A new perspective on safeguarding sight

Anida Pharma Inc. (Anida) is a preclinical stage biopharmaceutical company developing novel therapies that leverage the body’s endogenous repair system to repair and prevent vision loss.

The company’s pipeline is based on endogenously derived molecules that regulate the body’s physiological response to inflammation and stimulate cell repair. The therapeutic modality has broad application across diseases where degenerative processes may lead to permanent loss of eye function.